HKSE · Stocky rates: Avoid

LIPPO CHINA RES (0156.HK)

HK$1.29 ▼ -0.39% as of 6 Oct, 04:01

Stocky turns companies like LIPPO CHINA RES into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
18
/ 100
Avoid

What Stocky thinks

Stocky rates LIPPO CHINA RES at 18/100 based on business quality, leadership alignment, valuation.

Compounder Score
35/100
Business quality — profitability, growth, capital efficiency.
Resilience
0/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
28/100
Valuation vs peers and history — is this a good price to pay?
C
Fragile — its debt or losses could cause real trouble.

How safely LIPPO CHINA RES is financed, graded A++ (strongest) to C from the last five years of accounts: debt against earnings, interest cover, cash against debt, how high and steady profit margins are, return on capital, and whether it generated cash every year. Not part of the Stocky score.

What Stocky gives investors that other tools don't

Every stock is scored across six dimensions built to answer one question — can this business keep compounding? — without a Bloomberg subscription. Here's the actual snapshot for LIPPO CHINA RES:

18
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation fused into a single 0–100 number. When you see 18/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

—
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

0
RESILIENCE

Resilience Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

We don't claim a backtest. The top-scoring basket is recorded every month and measured against the S&P 500 from that date onward — judged on what it said before the outcome was known. The record is young, and published as it stands.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

LIPPO CHINA RES (0156.HK) — frequently asked

Is LIPPO CHINA RES (0156.HK) a good investment right now?

Stocky rates LIPPO CHINA RES (0156.HK) at 18/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation into a single number.

What is 0156.HK's Stocky Verdict?

0156.HK's current Stocky Verdict is 18/100, placing it in the "Avoid" band. This composite combines a 35/100 Compounder score, Leadership, Moat rating.

Does LIPPO CHINA RES have a competitive moat?

Stocky hasn't finalised a Moat Score for LIPPO CHINA RES yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is LIPPO CHINA RES's leadership aligned with shareholders?

Leadership Alignment for LIPPO CHINA RES is under analysis. Stocky scores founder tenure, insider ownership, CEO compensation multiple-of-salary, and long-term shareholder value creation.

What are the biggest risks to 0156.HK?

LIPPO CHINA RES's Resilience Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to LIPPO CHINA RES.

This is just the surface. See the whole picture on LIPPO CHINA RES.

Sign up free and unlock the full analysis on 0156.HK — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering 0156.HK — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Resilience Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for 0156.HK.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how 0156.HK changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to 0156.HK?" · "Is 0156.HK overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
18
/ 100 · Avoid

See LIPPO CHINA RES the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in 0156.HK would be worth today.
Practice portfolio
Buy 0156.HK with virtual money and track it — zero risk.
Free · no real money · learn by doing Open 0156.HK in Stocky →

Or jump straight to the interactive dashboard for 0156.HK in the app.